Tenax Therapeutics: Double Or Nothing (NASDAQ:TENX)
· seekingalpha.com
Tenax Therapeutics, Inc.'s oral levosimendan's Phase 3 LEVEL data is a binary catalyst. Click here to read why TENX stock is upgraded to Hold.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions...